Formica D1(2-6 8 10 12 15 20 30 200) Dps 1 D Drops is a Health Canada–registered human drug (DIN 02068974) held by Weleda AG Heilmittelbetriebe, containing Formica Rufa. Health Canada lists its status as Cancelled Post Market (status date 22 Dec 1997). Nexara Health has matched 13 registrations of Formica Rufa across 2 other regulated markets.
Health Canada registration
| DIN | 02068974 |
|---|---|
| Brand name | Formica D1(2-6 8 10 12 15 20 30 200) Dps |
| Active ingredient | Formica Rufa |
| Strength | 1 D |
| Dosage form | Drops |
| Route | Oral |
| Company | Weleda AG Heilmittelbetriebe |
| Status | Cancelled Post Market — 22 Dec 1997 |
| Class | Human |
| ATC | |
| AHFS | 92:02.00* ; See footnote |
| Regulator record | Health Canada DPD entry · Product monograph |
Formica Rufa registered in other markets
13 registrations of the same molecule in 2 national registries outside Canada (first 10 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Netherlands | Formica rufa | BOIRON (Messimy) | 8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K# | Uitsluitend apotheek of drogist | EU national register | |
| Netherlands | Formica rufa | BOIRON (Messimy) | 8 DH t/m 60 DH#4 CH t/m 200 CH#7 K t/m 100.000K# | Globuli | Uitsluitend apotheek of drogist | EU national register |
| United States | Bestmade Natural Products Formica Rufa | Bestmade Natural Products | Tablet, Soluble | listed | FDA NDC | |
| United States | Formica rufa | Boiron | Pellet | listed | FDA NDC | |
| United States | Formica rufa | Boiron | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC | |
| United States | Formica Rufa | Hahnemann Laboratories, INC. | Pellet | listed | FDA NDC |
See every manufacturer of Formica Rufa worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Formica D1(2-6 8 10 12 15 20 30 200) Dps (DIN 02068974) marketed in Canada?
No. Health Canada lists DIN 02068974 as Cancelled Post Market as of 22 Dec 1997.
Who holds the Canadian licence for this product?
Weleda AG Heilmittelbetriebe is the company of record in the Health Canada Drug Product Database.
Is Formica Rufa registered outside Canada?
Yes — Nexara Health has matched 13 registrations in 2 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02068974, status date 1997-12-22; national medicine registries: EU national register, FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02068974, status date 1997-12-22; national medicine registries: EU national register, FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02068974, status date 1997-12-22; national medicine registries: EU national register, FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.